Joseph P. O'Connell
2020 - Odonate Therapeutics
In 2020, Joseph P. O'Connell earned a total compensation of $1.4M as Chief Medical Officer at Odonate Therapeutics, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $142,400 |
|---|---|
| Option Awards | $828,858 |
| Salary | $374,800 |
| Other | $26,194 |
| Total | $1,372,252 |
O'Connell received $828.9K in option awards, accounting for 60% of the total pay in 2020.
O'Connell also received $142.4K in non-equity incentive plan, $374.8K in salary and $26.2K in other compensation.
Rankings
In 2020, Joseph P. O'Connell's compensation ranked 7,247th out of 13,090 executives tracked by ExecPay. In other words, O'Connell earned more than 44.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,247 out of 13,090 | 45th |
Division Manufacturing | 3,031 out of 5,624 | 46th |
Major group Chemicals And Allied Products | 1,223 out of 2,257 | 46th |
Industry group Drugs | 1,056 out of 1,957 | 46th |
Industry Pharmaceutical Preparations | 789 out of 1,462 | 46th |
Source: SEC filing on June 1, 2021.
O'Connell's colleagues
We found two more compensation records of executives who worked with Joseph P. O'Connell at Odonate Therapeutics in 2020.
News
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2020 pay falls 31% to $1.4M
June 1, 2021
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2019 pay jumps 37% to $2M
May 15, 2020
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2018 pay jumps 465% to $1.4M
June 24, 2019